Replies to post #3817 on VistaGen Therapeutics Inc (VTGN)

[ronpopeil]

same here. expecting trial to wrap up end of 2018 and data first quarter or half of 2019. if efficacy is shown, i think we can easily see $20. my crazy side says $40+ but who knows. av101 is a pipeline in of itself and we also have that nasal drug that could be huge too. strong data will put a lot of eyeballs on us and people will discover how much is going on here. you'd have to think agn or jnj will be all over us. the wait shouldn't be too much longer

[Rocketstockpix]

https://www.cnbc.com/2019/01/11/biotech-stocks-are-off-to-the-best-start-of-the-year-since-2012-.html